ArticlePloS one2019

NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin.

Angelique M L Scantlebery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.